MX368177B - Proceso continuo de múltiples etapas para purificar anticuerpos. - Google Patents

Proceso continuo de múltiples etapas para purificar anticuerpos.

Info

Publication number
MX368177B
MX368177B MX2015015482A MX2015015482A MX368177B MX 368177 B MX368177 B MX 368177B MX 2015015482 A MX2015015482 A MX 2015015482A MX 2015015482 A MX2015015482 A MX 2015015482A MX 368177 B MX368177 B MX 368177B
Authority
MX
Mexico
Prior art keywords
multistep process
purifying antibodies
continuous multistep
continuous
antibodies
Prior art date
Application number
MX2015015482A
Other languages
English (en)
Spanish (es)
Other versions
MX2015015482A (es
Inventor
Duthe Didier
Landric-Burtin Laure
Hemet Céline
Mothes Benoît
Original Assignee
Sanofi Sa
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Sanofi Sa filed Critical Sanofi Sa
Publication of MX2015015482A publication Critical patent/MX2015015482A/es
Publication of MX368177B publication Critical patent/MX368177B/es

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07KPEPTIDES
    • C07K16/00Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies
    • C07K16/06Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies from serum
    • C07K16/065Purification, fragmentation
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07KPEPTIDES
    • C07K1/00General methods for the preparation of peptides, i.e. processes for the organic chemical preparation of peptides or proteins of any length
    • C07K1/14Extraction; Separation; Purification
    • C07K1/16Extraction; Separation; Purification by chromatography
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07KPEPTIDES
    • C07K1/00General methods for the preparation of peptides, i.e. processes for the organic chemical preparation of peptides or proteins of any length
    • C07K1/14Extraction; Separation; Purification
    • C07K1/36Extraction; Separation; Purification by a combination of two or more processes of different types
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07KPEPTIDES
    • C07K16/00Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies
    • C07K16/06Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies from serum
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07KPEPTIDES
    • C07K16/00Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies
    • C07K16/40Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies against enzymes
    • CCHEMISTRY; METALLURGY
    • C12BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12MAPPARATUS FOR ENZYMOLOGY OR MICROBIOLOGY; APPARATUS FOR CULTURING MICROORGANISMS FOR PRODUCING BIOMASS, FOR GROWING CELLS OR FOR OBTAINING FERMENTATION OR METABOLIC PRODUCTS, i.e. BIOREACTORS OR FERMENTERS
    • C12M47/00Means for after-treatment of the produced biomass or of the fermentation or metabolic products, e.g. storage of biomass
    • C12M47/12Purification

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Biochemistry (AREA)
  • Genetics & Genomics (AREA)
  • Biophysics (AREA)
  • Medicinal Chemistry (AREA)
  • Molecular Biology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Engineering & Computer Science (AREA)
  • Immunology (AREA)
  • Analytical Chemistry (AREA)
  • Biotechnology (AREA)
  • Wood Science & Technology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Zoology (AREA)
  • General Engineering & Computer Science (AREA)
  • Sustainable Development (AREA)
  • Microbiology (AREA)
  • Biomedical Technology (AREA)
  • Peptides Or Proteins (AREA)
  • Preparation Of Compounds By Using Micro-Organisms (AREA)
  • Water Supply & Treatment (AREA)
  • Oncology (AREA)
  • Cell Biology (AREA)
  • Treatment Of Liquids With Adsorbents In General (AREA)
MX2015015482A 2013-05-06 2014-05-06 Proceso continuo de múltiples etapas para purificar anticuerpos. MX368177B (es)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
EP13305593 2013-05-06
PCT/EP2014/059246 WO2014180852A1 (fr) 2013-05-06 2014-05-06 Procédé continu à étapes multiples pour la purification d'anticorps

Publications (2)

Publication Number Publication Date
MX2015015482A MX2015015482A (es) 2016-03-21
MX368177B true MX368177B (es) 2019-09-23

Family

ID=48430636

Family Applications (1)

Application Number Title Priority Date Filing Date
MX2015015482A MX368177B (es) 2013-05-06 2014-05-06 Proceso continuo de múltiples etapas para purificar anticuerpos.

Country Status (19)

Country Link
US (1) US10793622B2 (fr)
EP (2) EP3301115B1 (fr)
JP (2) JP6463734B2 (fr)
KR (1) KR102272851B1 (fr)
CN (2) CN116003579A (fr)
AU (1) AU2014264697B2 (fr)
BR (1) BR112015027812B1 (fr)
CA (1) CA2911462C (fr)
CY (1) CY1125281T1 (fr)
DK (2) DK2994485T3 (fr)
ES (2) ES2905675T3 (fr)
HU (2) HUE038741T2 (fr)
IL (1) IL242408B (fr)
MX (1) MX368177B (fr)
NO (1) NO2994485T3 (fr)
RU (1) RU2662668C2 (fr)
SG (1) SG11201508968XA (fr)
TW (2) TWI631132B (fr)
WO (1) WO2014180852A1 (fr)

Families Citing this family (35)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US9458450B2 (en) 2012-03-15 2016-10-04 Flodesign Sonics, Inc. Acoustophoretic separation technology using multi-dimensional standing waves
US10704021B2 (en) 2012-03-15 2020-07-07 Flodesign Sonics, Inc. Acoustic perfusion devices
US9950282B2 (en) 2012-03-15 2018-04-24 Flodesign Sonics, Inc. Electronic configuration and control for acoustic standing wave generation
US10967298B2 (en) 2012-03-15 2021-04-06 Flodesign Sonics, Inc. Driver and control for variable impedence load
DK2911759T3 (da) * 2012-10-24 2024-09-16 Genzyme Corp Eluering af biomolekyler fra multimodale harpikser under anvendelse af mes og mops som modifikatorer af den mobile fase
KR20160054597A (ko) * 2013-09-17 2016-05-16 가부시키가이샤 가네카 신규 항체 정제 방법 및 그로부터 얻어지는 항체, 및 양이온 교환기를 사용한 신규 항체 정제법 및 그로부터 얻어지는 항체
US9725710B2 (en) 2014-01-08 2017-08-08 Flodesign Sonics, Inc. Acoustophoresis device with dual acoustophoretic chamber
GB201503578D0 (en) * 2015-03-03 2015-04-15 Ge Healthcare Bio Sciences Ab Sanitization method for affinity chromatography matrices
US11021699B2 (en) 2015-04-29 2021-06-01 FioDesign Sonics, Inc. Separation using angled acoustic waves
US11708572B2 (en) 2015-04-29 2023-07-25 Flodesign Sonics, Inc. Acoustic cell separation techniques and processes
US11377651B2 (en) 2016-10-19 2022-07-05 Flodesign Sonics, Inc. Cell therapy processes utilizing acoustophoresis
EP3015542A1 (fr) * 2015-05-07 2016-05-04 Bayer Technology Services GmbH Installation modulaire et procédé de production continue, présentant une réduction de germe et/ou préparation d'un produit
US11474085B2 (en) 2015-07-28 2022-10-18 Flodesign Sonics, Inc. Expanded bed affinity selection
US11459540B2 (en) 2015-07-28 2022-10-04 Flodesign Sonics, Inc. Expanded bed affinity selection
US20170101437A1 (en) * 2015-10-09 2017-04-13 Hetero Drugs Ltd. Process for purification of darbepoetin alfa
US11214789B2 (en) 2016-05-03 2022-01-04 Flodesign Sonics, Inc. Concentration and washing of particles with acoustics
US11085035B2 (en) 2016-05-03 2021-08-10 Flodesign Sonics, Inc. Therapeutic cell washing, concentration, and separation utilizing acoustophoresis
US20190211055A1 (en) * 2016-09-14 2019-07-11 Kinbio Ltd. Methods of purifying and qualifying antibodies
WO2018075830A1 (fr) 2016-10-19 2018-04-26 Flodesign Sonics, Inc. Extraction par affinité de cellules par un procédé acoustique
KR20190131082A (ko) * 2017-03-24 2019-11-25 카운슬 오브 사이언티픽 앤드 인더스트리얼 리서치 재조합 항체 단편을 정제하는 방법
GB201711481D0 (en) * 2017-07-17 2017-08-30 Ucb Biopharma Sprl Protein purification
EP3676375A4 (fr) * 2017-08-31 2021-04-07 Green Cross Corporation Procédé de purification d'une protéine de sulfatase
WO2019118921A1 (fr) 2017-12-14 2019-06-20 Flodesign Sonics, Inc. Circuit d'excitation et circuit de commande de transducteur acoustique
CN111902720A (zh) 2018-03-21 2020-11-06 沃特世科技公司 基于非抗体高亲和力的样品制备、吸附剂、装置和方法
EP3546475A1 (fr) * 2018-03-27 2019-10-02 Sanofi Processus d'écoulement intégral pour purifier des protéines recombinées
US12071607B2 (en) * 2018-06-01 2024-08-27 Lonza Ltd. Midscale model for organic growth and phasing
KR102337683B1 (ko) * 2018-09-21 2021-12-13 주식회사 녹십자 고효율 항-tfpi 항체 조성물
EP3636657A1 (fr) 2018-10-08 2020-04-15 Ablynx N.V. Procédé de purification d'anticorps sans chromatographie
WO2020084503A1 (fr) * 2018-10-26 2020-04-30 Cadila Healthcare Limited Composition comprenant un anticorps ayant un niveau réduit de variants basiques de celui-ci
WO2020183332A1 (fr) * 2019-03-11 2020-09-17 Intas Pharmaceuticals Ltd. Purification d'adalimumab à l'aide d'une chromatographie en tandem
EP3947705A1 (fr) * 2019-04-03 2022-02-09 Genzyme Corporation Production en continu de protéines recombinées
WO2020258704A1 (fr) * 2019-06-28 2020-12-30 信达生物制药(苏州)有限公司 Procédé chromatographique à écoulement continu sans interruption
KR102154952B1 (ko) * 2020-02-21 2020-09-10 프레스티지바이오로직스 주식회사 아달리무맙의 Non-Protein A 정제방법
CN112574321B (zh) * 2020-12-30 2023-10-20 上海赛金生物医药有限公司 一种捕获单克隆抗体-肿瘤坏死因子融合蛋白的亲和纯化方法
WO2022234412A1 (fr) 2021-05-03 2022-11-10 Lupin Limited Procédé de purification de protéines de fusion fc

Family Cites Families (34)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
KR930008447B1 (ko) 1987-10-23 1993-09-04 쉐링 코포레이션 단백질 정제방법
CA2106612C (fr) 1993-09-21 2001-02-06 Diana Pliura Processus de chromatographie a deplacement
RU2145873C1 (ru) 1993-09-21 2000-02-27 Хемосол Инк. Способ очистки гемоглобина в коммерческом масштабе
US5891741A (en) 1997-05-16 1999-04-06 Coulter International Corp. Antibody-aminodextran-phycobiliprotein conjugates
CN1136317C (zh) 1999-03-12 2004-01-28 中国人民解放军第四军医大学 单克隆抗体双段和单段的制备方法
US20020009445A1 (en) 2000-07-12 2002-01-24 Yansheng Du Human beta-amyloid antibody and use thereof for treatment of alzheimer's disease
US6602855B2 (en) 2001-04-30 2003-08-05 Syn X Pharma, Inc. Biopolymer marker indicative of disease state having a molecular weight of 1449 daltons
CN1504482A (zh) 2002-12-03 2004-06-16 北京优力凯生物技术有限责任公司 无细胞百日咳抗原蛋白的分离纯化方法
EP2455401B1 (fr) 2004-04-21 2018-01-24 The Brigham and Women's Hospital, Inc. Anticorps se liant à la glucosamine poly-n-acétyle (pnag/dpnag)
JP4831436B2 (ja) 2004-10-21 2011-12-07 ジーイー・ヘルスケア・バイオサイエンス・アクチボラグ クロマトグラフィーリガンド
CN107033243B (zh) 2005-03-23 2020-12-15 根马布股份公司 用于治疗多发性骨髓瘤的cd38抗体
CN1814775A (zh) 2005-12-06 2006-08-09 中国海洋大学 一种抗病毒活性寡聚肽的制备方法
EP1914242A1 (fr) * 2006-10-19 2008-04-23 Sanofi-Aventis Nouveau anticorps Anti-CD38 pour le traitement du cancer
US8399620B2 (en) 2007-07-11 2013-03-19 Novo Nordisk A/S Purification of factor VIII using a mixed-mode or multimodal resin
MY158903A (en) 2007-11-16 2016-11-30 Univ Rockefeller Antibodies specific for the protofibril form of beta-amyloid protein
TWI472339B (zh) 2008-01-30 2015-02-11 Genentech Inc 包含結合至her2結構域ii之抗體及其酸性變異體的組合物
US20110129468A1 (en) * 2008-02-29 2011-06-02 Biogen Idec Ma Inc. Purified immunoglobulin fusion proteins and methods of their purification
JP2011523408A (ja) * 2008-05-15 2011-08-11 ノボ・ノルデイスク・エー/エス 抗体精製方法
EP2321336A1 (fr) * 2008-07-18 2011-05-18 Talecris Biotherapeutics, Inc. Procédé de préparation des inhibiteurs d'alpha-1 protéinase
EP2360183B1 (fr) 2008-12-19 2016-07-27 Takeda Pharmaceutical Company Limited Méthode de purification anticorps par chromatographie a mode mixte utilisant une solution de chargement contenant arginine
EP2376523A4 (fr) 2009-01-13 2012-11-28 Ge Healthcare Bio Sciences Ab Précipitation de biomolécules au moyen de polymères chargés négativement
KR101224468B1 (ko) * 2009-05-20 2013-01-23 주식회사 파멥신 신규한 형태의 이중표적항체 및 그 용도
US8536316B2 (en) * 2009-08-07 2013-09-17 Emd Millipore Corporation Methods for purifying a target protein from one or more impurities in a sample
US9527010B2 (en) * 2009-09-25 2016-12-27 Ge Healthcare Bio-Sciences Corp. Separation system and method
WO2011049798A1 (fr) * 2009-10-20 2011-04-28 Merck Sharp & Dohme Corp. Utilisation de la chromatographie en mode mixte pour la capture et la purification de produits d'anticorps de base
EP2695889A1 (fr) * 2009-12-29 2014-02-12 Dr. Reddy's Laboratories Limited Purification des protéines par échange d'ions
ES2534936T3 (es) 2010-08-02 2015-04-30 Ratiopharm Gmbh Método para producir y purificar una sialiltransferasa soluble activa
WO2012125735A1 (fr) * 2011-03-15 2012-09-20 Abott Laboratories Approche intégrée à isolement et purification d'anticorps
ES2784628T3 (es) 2011-03-29 2020-09-29 Glaxosmithkline Llc Sistema de tampón para purificación de proteína
CN103874913B (zh) 2011-06-17 2017-04-26 罗氏血液诊断股份有限公司 用于生物样品的组织加工的溶液
WO2013028330A2 (fr) 2011-08-19 2013-02-28 Emd Millipore Corporation Procédés pour réduire le niveau d'une ou de plusieurs impuretés dans un échantillon pendant un procédé de purification de protéines
EP2578286A1 (fr) * 2011-10-04 2013-04-10 Merck Patent GmbH Procédé et appareil de purification chromatographique
IN2014CN03555A (fr) * 2011-10-25 2015-07-03 Onclave Therapeutics Ltd
WO2013075740A1 (fr) * 2011-11-23 2013-05-30 Sanofi Procédé de purification d'anticorps

Also Published As

Publication number Publication date
EP2994485B1 (fr) 2018-01-10
TW201522363A (zh) 2015-06-16
HUE057119T2 (hu) 2022-04-28
ES2665645T3 (es) 2018-04-26
MX2015015482A (es) 2016-03-21
RU2662668C2 (ru) 2018-07-26
CY1125281T1 (el) 2023-06-09
TWI631132B (zh) 2018-08-01
AU2014264697A1 (en) 2015-11-26
RU2015151869A (ru) 2017-06-13
US20160083454A1 (en) 2016-03-24
EP2994485A1 (fr) 2016-03-16
KR20160005047A (ko) 2016-01-13
CA2911462C (fr) 2021-04-06
TW201908331A (zh) 2019-03-01
DK2994485T3 (en) 2018-04-23
CN116003579A (zh) 2023-04-25
IL242408B (en) 2020-04-30
CA2911462A1 (fr) 2014-11-13
BR112015027812B1 (pt) 2021-03-30
JP6463734B2 (ja) 2019-02-06
WO2014180852A1 (fr) 2014-11-13
BR112015027812A2 (pt) 2017-07-25
US10793622B2 (en) 2020-10-06
EP3301115B1 (fr) 2021-11-10
KR102272851B1 (ko) 2021-07-02
EP3301115A1 (fr) 2018-04-04
TWI675041B (zh) 2019-10-21
ES2905675T3 (es) 2022-04-11
DK3301115T3 (da) 2022-01-31
CN105358572A (zh) 2016-02-24
NO2994485T3 (fr) 2018-06-09
AU2014264697B2 (en) 2019-08-22
JP2019104735A (ja) 2019-06-27
SG11201508968XA (en) 2015-11-27
JP2016519137A (ja) 2016-06-30
HUE038741T2 (hu) 2018-11-28

Similar Documents

Publication Publication Date Title
MX2015015482A (es) Proceso continuo de multiples etapas para purificar anticuerpos.
MX364908B (es) Purificación de proteínas usando amortiguador bis-tris.
HK1217344A1 (zh) 單克隆抗體的純化工序
FR3025515B1 (fr) Procede de purification d'un anticorps monoclonal
MX2015015188A (es) Metodo de clonacion, expresion y purificacion novedoso para la preparacion de ranibizumab.
EA201600429A1 (ru) Способ очистки 2,5-дихлорфенола
IL265016B (en) A method for purifying antibodies
EP2987801A4 (fr) Procédé de purification d'une protéine d'anticorps
HUE049661T2 (hu) Eljárás biomassza hidrolizátum tisztítására
EP3291837A4 (fr) Cocktails d'anticorps monoclonaux pour le traitement d'infections à ebola
EP3092002A4 (fr) Procédé de purification d'anticorps monoclonaux
MX2014013754A (es) Metodos de cristalizacion para la purificacion de anticuerpos monoclonales.
IL277056A (en) Methods for purifying antibodies
MX2015010006A (es) Purificacion de proteinas mejorada a traves de una etapa de desglicosilacion.
IL289959A (en) Antibody purification methods
GB201911685D0 (en) Process for purifying monoclonal antibodies
MX2019006783A (es) Procedimiento para la preparacion de 4-amino-1-( (1s, 4r, 5s) -2-fluoro-4,5-dihidroxi-3-hidroximetil-ciclopent-2-enil)-1h-pirim idin-2-ona.
MX2019011343A (es) Un procedimiento para la purificacion de fragmentos de anticuerpos recombinantes.
ZA201604024B (en) Improved feeding strategies and purification processes for monoclonal antibody production
FR3027821B1 (fr) Procede de purification d'oses.
IL276816A (en) Antibody purification
BR112016012664A2 (pt) Processo de purificação de 2,5-diclorofenol
RU2012143225A (ru) Способ выделения и очистки иммобилизованного фермента
TH1501001171A (th) กระบวนการสำหรับการแยกก๊าซกรดออกจากกระแสของไหลที่ประกอบด้วยน้ำ
IN2014CH01012A (fr)

Legal Events

Date Code Title Description
FG Grant or registration